Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer

Show other versions (1)

Background MammaPrint was developed as a diagnostic tool to predict risk of breast cancer metastasis using the expression of 70 genes. To better understand the tumor biology assessed by MammaPrint, we interpreted the biological functions of the 70-genes and showed how the genes reflect the six hallm...

Full description

Bibliographic Details
Main Authors:	Sun Tian, Paul Roepman, Laura J van't Veer, Rene Bernards, Femke De Snoo, Annuska M Glas
Format:	Article
Language:	English
Published:	SAGE Publishing 2010-01-01
Series:	Biomarker Insights
Online Access:	https://doi.org/10.4137/BMI.S6184

Similar Items

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer
by: Annuska M Glas, et al.
Published: (2010-11-01)

Prognostic Value of MammaPrint in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-01-01)

Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-12-01)

A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients.
by: Timothy J Molloy, et al.
Published: (2012-01-01)

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
by: Hatem Soliman, et al.
Published: (2020-01-01)

A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility
by: Witteveen Anke T, et al.
Published: (2009-08-01)

P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
by: G.-J. Liefers, et al.
Published: (2023-03-01)

The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
by: Ettienne J. Myburgh, et al.
Published: (2021-10-01)

RE: The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
by: Fabio Postiglione Mansani, et al.
Published: (2022-04-01)

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens
by: M. Kleijn, et al.
Published: (2021-04-01)

A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer
by: Young Joo Lee, et al.
Published: (2021-12-01)

Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.
by: Denise M Wolf, et al.
Published: (2014-01-01)

Converting a breast cancer microarray signature into a high-throughput diagnostic test
by: Warmoes Marc O, et al.
Published: (2006-10-01)

MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.
by: Andreas Bösl, et al.
Published: (2017-01-01)

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer
by: Christos Vaklavas, et al.
Published: (2020-02-01)

Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer
by: Young Sol Hwang, et al.
Published: (2022-12-01)

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
by: Alberto Peláez-García, et al.
Published: (2017-01-01)

Platelets in the tumor microenvironment and their biological effects on cancer hallmarks
by: Lilan Chen, et al.
Published: (2023-03-01)

Invasion and Metastasis as a Central Hallmark of Breast Cancer
by: Trishna Saha, et al.
Published: (2021-08-01)

HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
by: Behzad Mansoori, et al.
Published: (2021-10-01)

Allicin and Cancer Hallmarks
by: Wamidh H. Talib, et al.
Published: (2024-03-01)

The Hallmarks of Flavonoids in Cancer
by: Luis Gustavo Saboia Ponte, et al.
Published: (2021-04-01)

Melatonin and Cancer Hallmarks
by: Wamidh H. Talib
Published: (2018-02-01)

The microbiome and the hallmarks of cancer.
by: Laura E Fulbright, et al.
Published: (2017-09-01)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
by: Li-Na Yu, et al.
Published: (2019-12-01)

A framework to predict the applicability of Oncotype DX, MammaPrint, and E2F4 gene signatures for improving breast cancer prognostic prediction
by: Kevin Yao, et al.
Published: (2022-02-01)

Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review
by: Celia García-Chico, et al.
Published: (2023-01-01)

Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
by: Castellanos G, et al.
Published: (2023-03-01)

Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body.
by: Emanuel M Campoy, et al.
Published: (2016-01-01)

The gene regulatory network for breast cancer: Integrated regulatory landscape of cancer hallmarks
by: Frank eEmmert-Streib, et al.
Published: (2014-02-01)

P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study
by: E. Fiorino, et al.
Published: (2023-03-01)

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris
by: Laurence Slembrouck, et al.
Published: (2019-12-01)

CK2 and the Hallmarks of Cancer
by: May-Britt Firnau, et al.
Published: (2022-08-01)

Purinergic Signaling in the Hallmarks of Cancer
by: Anaí del Rocío Campos-Contreras, et al.
Published: (2020-07-01)

Hallmarks of cancer—the new testament
by: Sasi S. Senga, et al.
Published: (2021-01-01)

NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer
by: Lili Yi, et al.
Published: (2022-06-01)

Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer
by: Rui-yuan Jiang, et al.
Published: (2023-09-01)

The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions
by: Máté A. Demény, et al.
Published: (2021-04-01)

P166 Budget impact of MammaPrint® in Patients with primary hormone receptor-positive, HER2-negative and non-metastatic early-stage breast cancer in France
by: D. Zarca, et al.
Published: (2023-03-01)

The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks
by: Máté A. Demény, et al.
Published: (2021-04-01)